These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9260574)

  • 1. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Jolobe OM
    J Intern Med; 1997 Jul; 242(1):88-9. PubMed ID: 9260574
    [No Abstract]   [Full Text] [Related]  

  • 2. Severe hyperkalaemia induced by trimethoprim in combination with an angiotensin-converting enzyme inhibitor in a patient with transplanted lungs.
    Bugge JF
    J Intern Med; 1996 Oct; 240(4):249-51. PubMed ID: 8918517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperkalemia and trimethoprim-sulfamethoxazole.
    Thomas RJ
    Ann Intern Med; 1996 Nov; 125(9):778; author reply 779-80. PubMed ID: 8929018
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe hyperkalaemia with prescription of potassium-retaining agents in an elderly patient.
    Martin J; Mourton S; Nicholls G
    N Z Med J; 2003 Aug; 116(1179):U542. PubMed ID: 14513088
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversible impairment of renal function associated with enalapril in a diabetic patient.
    Albareda MM; Corcoy R
    CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life threatening hyperkalemia and acidosis secondary to trimethoprim-sulfamethoxazole treatment.
    Margassery S; Bastani B
    J Nephrol; 2001; 14(5):410-4. PubMed ID: 11730276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iatrogenic hyperkalaemia--points to consider in diagnosis and management.
    Siamopoulos KC; Elisaf M; Katopodis K
    Nephrol Dial Transplant; 1998 Sep; 13(9):2402-6. PubMed ID: 9761538
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole associated with hyperkalemia.
    Marinella MA
    West J Med; 1997 Nov; 167(5):356-8. PubMed ID: 9392994
    [No Abstract]   [Full Text] [Related]  

  • 9. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
    Odawara M; Asano M; Yamashita K
    Diabet Med; 1997 Feb; 14(2):169-70. PubMed ID: 9047098
    [No Abstract]   [Full Text] [Related]  

  • 10. Electrocardiographic changes after shoulder arthroplasty.
    Marinella MA
    Heart Lung; 2008; 37(5):390-3. PubMed ID: 18790340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management.
    Perazella MA
    Drug Saf; 2000 Mar; 22(3):227-36. PubMed ID: 10738846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of hyperkalaemia with renin-angiotensin system blockades in maintenance haemodialysis patients.
    Han SW; Won YW; Yi JH; Kim HJ
    Nephrol Dial Transplant; 2007 Apr; 22(4):1150-5. PubMed ID: 17255126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin converting enzyme inhibitor fetopathy.
    Hegde AU; Parekji S; Ali US; Mehta KP
    Indian Pediatr; 1999 Jan; 36(1):79-82. PubMed ID: 10709127
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe hyperkalemia during very-low-calorie diets and angiotensin converting enzyme use.
    Stoltz ML; Andrews CE
    JAMA; 1990 Dec; 264(21):2737-8. PubMed ID: 2172575
    [No Abstract]   [Full Text] [Related]  

  • 15. Inducing hyperkalemia by converting enzyme inhibitors and heparin.
    Durand D; Ader JL; Rey JP; Tran-Van T; Lloveras JJ; Bernadet P; Suc JM
    Kidney Int Suppl; 1988 Sep; 25():S196-7. PubMed ID: 3184611
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recurrent anaphylaxis and angiotensin-converting enzyme inhibitors].
    del Mar San Miguel M; Enrique E; Gaig P; García-Ortega P
    Med Clin (Barc); 1999 Apr; 112(12):479. PubMed ID: 10320967
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combination therapy with ACE inhibitors and angiotensin receptor antagonists].
    Kisters K
    Internist (Berl); 1999 Jun; 40(6):678-9. PubMed ID: 10420325
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients.
    Baer JT; Sauer WH; Berlin JA; Kimmel SE
    Am J Cardiol; 2004 Aug; 94(4):479-81. PubMed ID: 15325933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug-related hyperkalemia resulted from spironolactone and angiotensin converting enzyme inhibitors therapy].
    Dutka M; Dzielski T; Wojciechowska J; Heller L; Trybus M
    Pol Merkur Lekarski; 1999 Aug; 7(38):69-70. PubMed ID: 10522422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone + ace inhibitor or sartan: risk of hyperkalaemia.
    Prescrire Int; 2004 Apr; 13(70):58. PubMed ID: 15148978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.